Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15454
Revised: April 8, 2014
Accepted: May 25, 2014
Published online: November 7, 2014
Processing time: 271 Days and 1.3 Hours
Gangliocytic paraganglioma (GP) is rare and has been regarded as benign in general with a good prognosis. We present a patient with duodenal GP showing a malignant and lethal clinical course. A 47-year-old male patient was found to have a duodenal tumor and enlarged regional lymph nodes. The patient initially underwent a pancreaticoduodenectomy to resect the tumor and involved lymph nodes completely. Histological and immunohistochemical analyses showed findings typical of GP. However, the distant metastatic lesions in the liver and pelvic cavity were rapidly observed after surgery. The patient underwent chemotherapy and radiotherapy, as well as a second surgery to partly remove the metastatic mass in the pelvic cavity. The histological examination revealed no significant difference in histological features between the primary duodenal tumor and the metastatic pelvic mass. However, the patient finally died of the tumor due to the recurrence of the residual pelvic lesion and increased liver mass. To our knowledge, this is the first report of lethal GP with multifocal metastases. Our case confirms that GP should be regarded as a malignant potential tumor with behavior code of “1”, rather than a benign tumor of “0”.
Core tip: This case for the first time presents a patient with duodenalgangliocytic paraganglioma showing distant metastases and a lethal clinical course. It indicates that gangliocytic paraganglioma should be regarded as a malignant potential tumor, rather than a benign tumor.